ClinicalTrials.gg
RecruitingNCT07550907Updated Jun 3, 2026

The Impact of Surgical Procedures on Postoperative Outcomes in Cataract Phacoemulsification and Analysis of Related Factors

An observational study in Age-related Cataract, sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University. Recruiting at 1 site in China. Open to participants aged 50 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University · Observational

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
50 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in Cataract by Zhongshan Ophthalmic Center, Sun Yat-sen University — 10 open to participants now, 10 under way, none of them phase 3. Cataract · Zhongshan Ophthalmic Center, Sun Yat-sen University.

Started
2026
with 3 others
Observational
6 of 19
5 open now
Registered
16th of 19
by date

Among the 19 studies in Cataract by Zhongshan Ophthalmic Center, Sun Yat-sen University, this one is one of 4 that started in 2026, is one of 6 observational ones, and was the 16th registered.

Cataract

1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.

Browse Cataract studies →

Open to participants now

10 of the 19 studies in Cataract by Zhongshan Ophthalmic Center, Sun Yat-sen University are open now, in 1 country. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Where they have run

Who these studies take

Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.

This study: 50 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Cataract by Zhongshan Ophthalmic Center, Sun Yat-sen University, or all of them as a file.
02

Study summary

The goal of this observational study is to evaluate the location of phacoemulsification tip measured by intraoperative OCT during cataract surgeries and its impact on early postoperative changes of cornea and visual acuity. The main question it aims to answer is:

In patients with age-related cataracts undergoing phacoemulsification, does the location (supracapsular, iris-lens diaphragm, or endocapsular) of the phaco tip affect postoperative corneal changes and visual acuity at early postoperative stage? Eyes having phacoemulsification for cataracts will receive intraoperative OCT imaging to evaluate the location of the phaco tip during surgery, and corneal changes and visual acuity will be measured postoperatively.

03

Conditions studied

  • Age-related Cataract

Browse trials for

04

Who can participate

Ages eligible
50 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients who are planning to receive phacoemulsification combined with intraocular lens implantation for unilateral/bilateral age-related cataract

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 50 years and ≤ 90 years
  • Diagnosis of unilateral/bilateral age-related cataract
  • Nuclear grade ≥2 in LOCSIII classification
  • Scheduled for cataract phacoemulsification combined with intraocular lens implantation
  • Pupil size ≥6mm after dilation
  • Corneal endothelial cell count ≥1500 cells/mm²

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of severe systemic disease (e.g., severe hypertension or Alzheimer's disease)
  • History of ocular trauma or surgery
  • Presence of other ocular diseases (such as glaucoma, diabetic retinopathy, or high myopia)
  • Other ocular factors that may complicate the surgery (such as small pupil, shallow anterior chamber)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Target follow-up
1 Month
Patient registry
Yes

Groups and cohorts

  • Phacoemulsification

    Procedure: cataract surgery

Interventions

  • Procedurecataract surgery

    Cataract phacoemulsification combined with intraocular lens implantation

06

What researchers measure

Primary outcomes

  1. Change in corneal thickness

    Corneal thickness measured by corneal endothelial specular microscope

    Time frame: postoperative day 1, week 1, and month 1

Secondary outcomes

  1. Change in corneal endothelial cell density

    Measured using corneal endothelial specular microscope

    Time frame: 1 day, 1 week, and 1 month postoperatively

  2. Best-corrected visual acuity

    Measured using ETDRS visual acuity protocol with ETDRS visual acuity chart by a masked examiner

    Time frame: 1 day, 1 week, and 1 month postoperatively

  3. Intraoperative and postoperative complications

    Monitored by cataract surgeons using intraoperative OCT and postoperative slit-lamp examination. Complications include Descemet membrane detachment, posterior capsule rupture, incision leakage, and etc.

    Time frame: Intraoperative, 1 day, 1 week, and 1 month postoperatively

Other outcomes

  1. Position of Phacoemulsification

    Swept-source intraoperative optical coherence tomography (SS-iOCT) will be used for real-time measurements throughout the surgery. The imaging depth will be set to 12 mm to ensure full visualization from the anterior corneal surface to the posterior lens surface. During phacoemulsification, a five-line scanning pattern will be applied, with the central line aligned with the phaco tip. The iris-lens diaphragm plane will be used as the reference standard on iOCT images. The phaco tip will be considered to be in the supracapsular space when positioned above this plane, at the iris-lens diaphragm plane when exactly at the plane, and in the endocapsular space when positioned below the plane. The duration of phaco tip manipulation in the supracapsular space, at the iris-lens diaphragm plane, and in the endocapsular space will be recorded throughout the phacoemulsification process.

    Time frame: During phacoemulsification

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Liu Z, Lin H, Jin L, Qu B, Liu J, Zheng Y, He M, Luo L, Liu Y. Swab Pressing vs Stromal Hydration to Prevent Incision Leakage and Transient Collapse of Anterior Chamber in Phacoemulsification: A Randomized Clinical Trial. JAMA Ophthalmol. 2023 Jun 1;141(6):574-581. doi: 10.1001/jamaophthalmol.2023.1491. PubMed 37166786 ↗
  • Liu Y, Zeng M, Liu X, Luo L, Yuan Z, Xia Y, Zeng Y. Torsional mode versus conventional ultrasound mode phacoemulsification: randomized comparative clinical study. J Cataract Refract Surg. 2007 Feb;33(2):287-92. doi: 10.1016/j.jcrs.2006.10.044. PubMed 17276271 ↗
  • Dewan T, Malik PK, Kumari R. Comparison of effective phacoemulsification time and corneal endothelial cell loss using 2 ultrasound frequencies. J Cataract Refract Surg. 2019 Sep;45(9):1285-1293. doi: 10.1016/j.jcrs.2019.04.015. Epub 2019 Jul 29. PubMed 31371150 ↗
  • Dewan T, Malik PK, Tomar P. Comparison of effective phacoemulsification time and corneal endothelial cell loss using three different ultrasound frequencies: A randomized controlled trial. Indian J Ophthalmol. 2022 Apr;70(4):1180-1185. doi: 10.4103/ijo.IJO_2163_21. PubMed 35326010 ↗
  • Liu Y, Jiang Y, Wu M, Liu Y, Zhang T. Bimanual microincision phacoemulsification in treating hard cataracts using different power modes. Clin Exp Ophthalmol. 2008 Jul;36(5):426-30. PubMed 18939349 ↗
  • Lundberg B, Jonsson M, Behndig A. Postoperative corneal swelling correlates strongly to corneal endothelial cell loss after phacoemulsification cataract surgery. Am J Ophthalmol. 2005 Jun;139(6):1035-41. doi: 10.1016/j.ajo.2004.12.080. PubMed 15953433 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Dec 2026, 8 months after the start.

Of 169 non-industry observational studies under Cataract, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 30. This study's planned 8 months is below that.

Counting every sponsor, half of 236 studies reached it within 16 months; a quarter within 9 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 15, 2026
First posted
Apr 24, 2026
StartActual
Apr 20, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Jun 30, 2027
Last update
Jun 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07550907
Responsible party
Zitian Liu (Dr., Zhongshan Ophthalmic Center, Sun Yat-sen University) — Principal investigator
First posted
Apr 24, 2026
Start date
Apr 20, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Jun 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion